Hetero starts supply of 60,000 vials of generic Remdesvir for treatment of Covid-19 patients

Covifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news